Enterococcus Infections
| العنوان: | Enterococcus Infections |
|---|---|
| المؤلفون: | Said MS; Rochester General Hospital, Tirthani E; Rochester General Hospital, Lesho E; Rochester Regional Health |
| المصدر: | 2022 Jan. |
| المصدر: | In: StatPearls |
| نوع المنشور: | Study Guide |
| اللغة: | English |
| بيانات الدورية: | Publisher: StatPearls Publishing Cited Medium: Internet |
| أسماء مطبوعة: | Treasure Island (FL) : StatPearls Publishing |
| مستخلص: | Enterococci are Gram-positive facultative anaerobic cocci in short and medium chains, first discovered in 1899 in the human gastrointestinal tract. They were recognized as a separate genus from streptococci by DNA hybridization and 16S rRNA sequencing in 1984. They are the first of the ESKAPE organisms ( Enterococci spp., Staphylococcus aureus , Klebsiella pneumoniae , Acinetobacter baumannii , Pseudomonas aeruginosa , Enterobacter spp.) highlighted by the WHO as rising causes of nosocomial and antibiotic-resistant infections in the last few decades threatening public health. Vancomycin-resistant enterococci (VRE) were first reported in 1933 in animals owing to the use of Avoparcin, which was a vancomycin analog used as an animal food additive. However, they were reported for the first time in humans in England in 1988, several years later. (Copyright © 2022, StatPearls Publishing LLC.) |
| References: | Fiore E, Van Tyne D, Gilmore MS. Pathogenicity of Enterococci. Microbiol Spectr. 2019 Jul;7(4). (PMID: PMC662943831298205) Zhen X, Lundborg CS, Sun X, Hu X, Dong H. Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review. Antimicrob Resist Infect Control. 2019;8:137. (PMID: PMC669293931417673) Raza T, Ullah SR, Mehmood K, Andleeb S. Vancomycin resistant Enterococci: A brief review. J Pak Med Assoc. 2018 May;68(5):768-772. (PMID: 29885179) Miller WR, Murray BE, Rice LB, Arias CA. Vancomycin-Resistant Enterococci: Therapeutic Challenges in the 21st Century. Infect Dis Clin North Am. 2016 Jun;30(2):415-439. (PMID: 27208766) Franz CM, Huch M, Abriouel H, Holzapfel W, Gálvez A. Enterococci as probiotics and their implications in food safety. Int J Food Microbiol. 2011 Dec 02;151(2):125-40. (PMID: 21962867) García-Solache M, Rice LB. The Enterococcus: a Model of Adaptability to Its Environment. Clin Microbiol Rev. 2019 Mar 20;32(2). (PMID: PMC643112830700430) Monticelli J, Knezevich A, Luzzati R, Di Bella S. Clinical management of non-faecium non-faecalis vancomycin-resistant enterococci infection. Focus on Enterococcus gallinarum and Enterococcus casseliflavus/flavescens. J Infect Chemother. 2018 Apr;24(4):237-246. (PMID: 29396199) Pinkes ME, White C, Wong CS. Native-valve Enterococcus hirae endocarditis: a case report and review of the literature. BMC Infect Dis. 2019 Oct 24;19(1):891. (PMID: PMC681404231651255) Mastroianni A. Enterococcus raffinosus endocarditis. First case and literature review. Infez Med. 2009 Mar;17(1):14-20. (PMID: 19359819) Reyes K, Bardossy AC, Zervos M. Vancomycin-Resistant Enterococci: Epidemiology, Infection Prevention, and Control. Infect Dis Clin North Am. 2016 Dec;30(4):953-965. (PMID: 27660091) Fernández-Hidalgo N, Escolà-Vergé L. Enterococcus faecalis Bacteremia: Consider an Echocardiography, But Consult an Infectious Diseases Specialist. J Am Coll Cardiol. 2019 Jul 16;74(2):202-204. (PMID: 31296292) Zheng JX, Li H, Pu ZY, Wang HY, Deng XB, Liu XJ, Deng QW, Yu ZJ. Bloodstream infections caused by Enterococcus spp: A 10-year retrospective analysis at a tertiary hospital in China. J Huazhong Univ Sci Technolog Med Sci. 2017 Apr;37(2):257-263. (PMID: 28397040) Ostrowsky BE, Trick WE, Sohn AH, Quirk SB, Holt S, Carson LA, Hill BC, Arduino MJ, Kuehnert MJ, Jarvis WR. Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med. 2001 May 10;344(19):1427-33. (PMID: 11346807) Chanderraj R, Millar JA, Patel TS, Read AF, Washer L, Kaye KS, Woods RJ. Vancomycin-Resistant Enterococcus Acquisition in a Tertiary Care Hospital: Testing the Roles of Antibiotic Use, Proton Pump Inhibitor Use, and Colonization Pressure. Open Forum Infect Dis. 2019 Apr;6(4):ofz139. (PMID: PMC647559231024976) Chiang HY, Perencevich EN, Nair R, Nelson RE, Samore M, Khader K, Chorazy ML, Herwaldt LA, Blevins A, Ward MA, Schweizer ML. Incidence and Outcomes Associated With Infections Caused by Vancomycin-Resistant Enterococci in the United States: Systematic Literature Review and Meta-Analysis. Infect Control Hosp Epidemiol. 2017 Feb;38(2):203-215. (PMID: 27825401) Gross PA, Harkavy LM, Barden GE, Flower MF. The epidemiology of nosocomial enterococcal urinary tract infection. Am J Med Sci. 1976 Jul-Aug;272(1):75-81. (PMID: 822713) Mikulska M, Del Bono V, Raiola AM, Bruno B, Gualandi F, Occhini D, di Grazia C, Frassoni F, Bacigalupo A, Viscoli C. Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance. Biol Blood Marrow Transplant. 2009 Jan;15(1):47-53. (PMID: 19135942) Bedini A, Codeluppi M, Cocchi S, Guaraldi G, Di Benedetto F, Venturelli C, Masetti M, Prati F, Mussini C, Borghi V, Girardis M, Gerunda GE, Rumpianesi F, Esposito R. Gram-positive bloodstream infections in liver transplant recipients: incidence, risk factors, and impact on survival. Transplant Proc. 2007 Jul-Aug;39(6):1947-9. (PMID: 17692662) Goh HMS, Yong MHA, Chong KKL, Kline KA. Model systems for the study of Enterococcal colonization and infection. Virulence. 2017 Nov 17;8(8):1525-1562. (PMID: PMC581048128102784) Ch'ng JH, Chong KKL, Lam LN, Wong JJ, Kline KA. Biofilm-associated infection by enterococci. Nat Rev Microbiol. 2019 Jan;17(2):82-94. (PMID: 30337708) Rello J, Campogiani L, Eshwara VK. Understanding resistance in enterococcal infections. Intensive Care Med. 2020 Feb;46(2):353-356. (PMID: 31792686) Gagetti P, Bonofiglio L, García Gabarrot G, Kaufman S, Mollerach M, Vigliarolo L, von Specht M, Toresani I, Lopardo HA. Resistance to β-lactams in enterococci. Rev Argent Microbiol. 2019 Apr-Jun;51(2):179-183. (PMID: 30243525) Rice LB, Bellais S, Carias LL, Hutton-Thomas R, Bonomo RA, Caspers P, Page MG, Gutmann L. Impact of specific pbp5 mutations on expression of beta-lactam resistance in Enterococcus faecium. Antimicrob Agents Chemother. 2004 Aug;48(8):3028-32. (PMID: PMC47848715273117) Mainardi JL, Legrand R, Arthur M, Schoot B, van Heijenoort J, Gutmann L. Novel mechanism of beta-lactam resistance due to bypass of DD-transpeptidation in Enterococcus faecium. J Biol Chem. 2000 Jun 02;275(22):16490-6. (PMID: 10748168) Mainardi JL, Morel V, Fourgeaud M, Cremniter J, Blanot D, Legrand R, Frehel C, Arthur M, Van Heijenoort J, Gutmann L. Balance between two transpeptidation mechanisms determines the expression of beta-lactam resistance in Enterococcus faecium. J Biol Chem. 2002 Sep 27;277(39):35801-7. (PMID: 12077139) Conceição N, da Silva LE, Darini AL, Pitondo-Silva A, de Oliveira AG. Penicillin-resistant, ampicillin-susceptible Enterococcus faecalis of hospital origin: pbp4 gene polymorphism and genetic diversity. Infect Genet Evol. 2014 Dec;28:289-95. (PMID: 25445645) Infante VH, Conceição N, de Oliveira AG, Darini AL. Evaluation of polymorphisms in pbp4 gene and genetic diversity in penicillin-resistant, ampicillin-susceptible Enterococcus faecalis from hospitals in different states in Brazil. FEMS Microbiol Lett. 2016 Apr;363(7). (PMID: 26903013) Ono S, Muratani T, Matsumoto T. Mechanisms of resistance to imipenem and ampicillin in Enterococcus faecalis. Antimicrob Agents Chemother. 2005 Jul;49(7):2954-8. (PMID: PMC116871715980374) Desbonnet C, Tait-Kamradt A, Garcia-Solache M, Dunman P, Coleman J, Arthur M, Rice LB. Involvement of the Eukaryote-Like Kinase-Phosphatase System and a Protein That Interacts with Penicillin-Binding Protein 5 in Emergence of Cephalosporin Resistance in Cephalosporin-Sensitive Class A Penicillin-Binding Protein Mutants in Enterococcus faecium. mBio. 2016 Apr 05;7(2):e02188-15. (PMID: PMC495951527048803) Costa Y, Galimand M, Leclercq R, Duval J, Courvalin P. Characterization of the chromosomal aac(6')-Ii gene specific for Enterococcus faecium. Antimicrob Agents Chemother. 1993 Sep;37(9):1896-903. (PMID: PMC1880898239603) Eliopoulos GM, Farber BF, Murray BE, Wennersten C, Moellering RC. Ribosomal resistance of clinical enterococcal to streptomycin isolates. Antimicrob Agents Chemother. 1984 Mar;25(3):398-9. (PMID: PMC1855316326668) Mederski-Samoraj BD, Murray BE. High-level resistance to gentamicin in clinical isolates of enterococci. J Infect Dis. 1983 Apr;147(4):751-7. (PMID: 6404994) Singh KV, Weinstock GM, Murray BE. An Enterococcus faecalis ABC homologue (Lsa) is required for the resistance of this species to clindamycin and quinupristin-dalfopristin. Antimicrob Agents Chemother. 2002 Jun;46(6):1845-50. (PMID: PMC12725612019099) Sharkey LK, Edwards TA, O'Neill AJ. ABC-F Proteins Mediate Antibiotic Resistance through Ribosomal Protection. mBio. 2016 Mar 22;7(2):e01975. (PMID: PMC480736727006457) Reynolds PE. Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur J Clin Microbiol Infect Dis. 1989 Nov;8(11):943-50. (PMID: 2532132) Arthur M, Courvalin P. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob Agents Chemother. 1993 Aug;37(8):1563-71. (PMID: PMC1880208215264) Shinabarger DL, Marotti KR, Murray RW, Lin AH, Melchior EP, Swaney SM, Dunyak DS, Demyan WF, Buysse JM. Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions. Antimicrob Agents Chemother. 1997 Oct;41(10):2132-6. (PMID: PMC1640829333037) Mendes RE, Deshpande LM, Castanheira M, DiPersio J, Saubolle MA, Jones RN. First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States. Antimicrob Agents Chemother. 2008 Jun;52(6):2244-6. (PMID: PMC241576818391032) Tran TT, Munita JM, Arias CA. Mechanisms of drug resistance: daptomycin resistance. Ann N Y Acad Sci. 2015 Sep;1354:32-53. (PMID: PMC496653626495887) Tran TT, Panesso D, Mishra NN, Mileykovskaya E, Guan Z, Munita JM, Reyes J, Diaz L, Weinstock GM, Murray BE, Shamoo Y, Dowhan W, Bayer AS, Arias CA. Daptomycin-resistant Enterococcus faecalis diverts the antibiotic molecule from the division septum and remodels cell membrane phospholipids. mBio. 2013 Jul 23;4(4). (PMID: PMC373518723882013) Sadowy E. Linezolid resistance genes and genetic elements enhancing their dissemination in enterococci and streptococci. Plasmid. 2018 Sep;99:89-98. (PMID: 30253132) Downing MA, Xiong J, Eshaghi A, McGeer A, Patel SN, Johnstone J. Vancomycin-Variable Enterococcal Bacteremia. J Clin Microbiol. 2015 Dec;53(12):3951-3. (PMID: PMC465211226424845) Sukumaran V, Cosh J, Thammavong A, Kennedy K, Ong CW. Vancomycin dependent Enterococcus: an unusual mutant? Pathology. 2019 Apr;51(3):318-320. (PMID: 30846227) Miller WR, Munita JM, Arias CA. Mechanisms of antibiotic resistance in enterococci. Expert Rev Anti Infect Ther. 2014 Oct;12(10):1221-36. (PMID: PMC443316825199988) Faron ML, Ledeboer NA, Buchan BW. Resistance Mechanisms, Epidemiology, and Approaches to Screening for Vancomycin-Resistant Enterococcus in the Health Care Setting. J Clin Microbiol. 2016 Oct;54(10):2436-47. (PMID: PMC503542527147728) NNIS System. National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1990-May 1999, issued June 1999. A report from the NNIS System. Am J Infect Control. 1999 Dec;27(6):520-32. (PMID: 10586157) Yim J, Smith JR, Rybak MJ. Role of Combination Antimicrobial Therapy for Vancomycin-Resistant Enterococcus faecium Infections: Review of the Current Evidence. Pharmacotherapy. 2017 May;37(5):579-592. (PMID: 28273381) Souhail B, Le Maréchal M, Manuello R, Chrétien R, Charlot P, Déroudilhes G, Della Guardia M, Blanc V, Fribourg A, Degand N, Roger PM. Antibiotic therapy for Enterococcus bacteraemia: warning for the antimicrobial stewardship team. Eur J Clin Microbiol Infect Dis. 2019 Nov;38(11):2087-2095. (PMID: 31350634) Dahl A, Iversen K, Tonder N, Hoest N, Arpi M, Dalsgaard M, Chehri M, Soerensen LL, Fanoe S, Junge S, Hoest U, Valeur N, Lauridsen TK, Fosbol E, Hoi-Hansen T, Bruun NE. Prevalence of Infective Endocarditis in Enterococcus faecalis Bacteremia. J Am Coll Cardiol. 2019 Jul 16;74(2):193-201. (PMID: 31296291) Dahl A, Miro JM, Bruun NE. Enterococcus faecalis bacteremia: please do the echo. Aging (Albany NY) 2019 Dec 12;11(23):10786-10787. (PMID: PMC693289131831716) Amat-Santos IJ, Ribeiro HB, Urena M, Allende R, Houde C, Bédard E, Perron J, DeLarochellière R, Paradis JM, Dumont E, Doyle D, Mohammadi S, Côté M, San Roman JA, Rodés-Cabau J. Prosthetic valve endocarditis after transcatheter valve replacement: a systematic review. JACC Cardiovasc Interv. 2015 Feb;8(2):334-346. (PMID: 25700757) Bayer AS, Seidel JS, Yoshikawa TT, Anthony BF, Guze LB. Group D enterococcal meningitis. Clinical and therapeutic considerations with report of three cases and review of the literature. Arch Intern Med. 1976 Aug;136(8):883-6. (PMID: 821410) Kurup A, Tee WS, Loo LH, Lin R. Infection of central nervous system by motile Enterococcus: first case report. J Clin Microbiol. 2001 Feb;39(2):820-2. (PMID: PMC8783111158162) Buchino JJ, Ciambarella E, Light I. Systemic group D streptococcal infection in newborn infants. Am J Dis Child. 1979 Mar;133(3):270-3. (PMID: 106722) Siegel JD, McCracken GH. Group D streptococcal infections. J Pediatr. 1978 Sep;93(3):542-3. (PMID: 99508) Shukla BS, Gauthier TP, Correa R, Smith L, Abbo L. Treatment considerations in vancomycin-resistant enterococcal bacteremia: daptomycin or linezolid? A review. Int J Clin Pharm. 2013 Oct;35(5):697-703. (PMID: 23893061) Teixeira LM, Facklam RR, Steigerwalt AG, Pigott NE, Merquior VL, Brenner DJ. Correlation between phenotypic characteristics and DNA relatedness within Enterococcus faecium strains. J Clin Microbiol. 1995 Jun;33(6):1520-3. (PMID: PMC2282077650178) Coque TM, Murray BE. Identification of Enterococcus faecalis strains by DNA hybridization and pulsed-field gel electrophoresis. J Clin Microbiol. 1995 Dec;33(12):3368-9. (PMID: PMC2287168586745) Tyrrell GJ, Bethune RN, Willey B, Low DE. Species identification of enterococci via intergenic ribosomal PCR. J Clin Microbiol. 1997 May;35(5):1054-60. (PMID: PMC2327029114380) Depardieu F, Perichon B, Courvalin P. Detection of the van alphabet and identification of enterococci and staphylococci at the species level by multiplex PCR. J Clin Microbiol. 2004 Dec;42(12):5857-60. (PMID: PMC53530015583325) Martinez RM, Bauerle ER, Fang FC, Butler-Wu SM. Evaluation of three rapid diagnostic methods for direct identification of microorganisms in positive blood cultures. J Clin Microbiol. 2014 Jul;52(7):2521-9. (PMID: PMC409774624808235) Deck MK, Anderson ES, Buckner RJ, Colasante G, Davis TE, Coull JM, Crystal B, Latta PD, Fuchs M, Fuller D, Harris W, Hazen K, Klimas LL, Lindao D, Meltzer MC, Morgan M, Shepard J, Stevens S, Wu F, Fiandaca MJ. Rapid detection of Enterococcus spp. direct from blood culture bottles using Enterococcus QuickFISH method: a multicenter investigation. Diagn Microbiol Infect Dis. 2014 Apr;78(4):338-42. (PMID: 24439447) Fang H, Ohlsson AK, Ullberg M, Ozenci V. Evaluation of species-specific PCR, Bruker MS, VITEK MS and the VITEK 2 system for the identification of clinical Enterococcus isolates. Eur J Clin Microbiol Infect Dis. 2012 Nov;31(11):3073-7. (PMID: 22706514) Baddour LM, Wilson WR, Bayer AS, Fowler VG, Tleyjeh IM, Rybak MJ, Barsic B, Lockhart PB, Gewitz MH, Levison ME, Bolger AF, Steckelberg JM, Baltimore RS, Fink AM, O'Gara P, Taubert KA, American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation. 2015 Oct 13;132(15):1435-86. (PMID: 26373316) Athan E, Cabiltes I, Coghill S, Bowe SJ. Silent but deadly: patients with enterococcal bacteraemia should be assessed for colorectal neoplasia. Med J Aust. 2019 Feb;210(2):86. (PMID: 30712310) Pericàs JM, Corredoira J, Moreno A, García-País MJ, Falces C, Rabuñal R, Mestres CA, Alonso MP, Marco F, Quintana E, Almela M, Paré JC, Llopis J, Castells A, Miró JM, Hospital Clínic and Hospital Lucus Augusti Infective Endocarditis Investigators Relationship Between Enterococcus faecalis Infective Endocarditis and Colorectal Neoplasm: Preliminary Results From a Cohort of 154 Patients. Rev Esp Cardiol (Engl Ed) 2017 Jun;70(6):451-458. (PMID: 27916708) Amarnani R, Rapose A. Colon cancer and enterococcus bacteremia co-affection: A dangerous alliance. J Infect Public Health. 2017 Sep-Oct;10(5):681-684. (PMID: 28143799) Maki DG, Agger WA. Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Medicine (Baltimore) 1988 Jul;67(4):248-69. (PMID: 3134590) Gullberg RM, Homann SR, Phair JP. Enterococcal bacteremia: analysis of 75 episodes. Rev Infect Dis. 1989 Jan-Feb;11(1):74-85. (PMID: 2916096) Watanakunakorn C, Patel R. Comparison of patients with enterococcal bacteremia due to strains with and without high-level resistance to gentamicin. Clin Infect Dis. 1993 Jul;17(1):74-8. (PMID: 8353250) Minassian MA, Lewis DA, Chattopadhyay D, Bovill B, Duckworth GJ, Williams JD. A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women. Int J Antimicrob Agents. 1998 Apr;10(1):39-47. (PMID: 9624542) Cole M, Ridley B. Absence of bioactive metabolites of ampicillin and amoxycillin in man. J Antimicrob Chemother. 1978 Nov;4(6):580-2. (PMID: 711656) Stevenson KB, Murray EW, Sarubbi FA. Enterococcal meningitis: report of four cases and review. Clin Infect Dis. 1994 Feb;18(2):233-9. (PMID: 8161632) Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, Dulgheru R, El Khoury G, Erba PA, Iung B, Miro JM, Mulder BJ, Plonska-Gosciniak E, Price S, Roos-Hesselink J, Snygg-Martin U, Thuny F, Tornos Mas P, Vilacosta I, Zamorano JL, ESC Scientific Document Group 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015 Nov 21;36(44):3075-3128. (PMID: 26320109) Gould FK, Denning DW, Elliott TS, Foweraker J, Perry JD, Prendergast BD, Sandoe JA, Spry MJ, Watkin RW, Working Party of the British Society for Antimicrobial Chemotherapy Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother. 2012 Feb;67(2):269-89. (PMID: 22086858) HAVARD CW, GARROD LP, WATERWORTH PM. Deaf or dead? A case of subacute bacterial endocarditis treated with penicillin and neomycin. Br Med J. 1959 Mar 14;1(5123):688-9. (PMID: PMC199310913629091) Mainardi JL, Gutmann L, Acar JF, Goldstein FW. Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis. Antimicrob Agents Chemother. 1995 Sep;39(9):1984-7. (PMID: PMC1628688540703) Burguer Moreira N, Nastro M, Vay C, Famiglietti Á, Rodríguez CH. [In vitro activity of ampicillin-ceftriaxone against Enterococcus faecalis isolates recovered from invasive infections]. Rev Argent Microbiol. 2016 Jan-Mar;48(1):57-61. (PMID: 26857425) Gavaldà J, Torres C, Tenorio C, López P, Zaragoza M, Capdevila JA, Almirante B, Ruiz F, Borrell N, Gomis X, Pigrau C, Baquero F, Pahissa A. Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides. Antimicrob Agents Chemother. 1999 Mar;43(3):639-46. (PMID: PMC8917310049280) Gavaldá J, Onrubia PL, Gómez MT, Gomis X, Ramírez JL, Len O, Rodríguez D, Crespo M, Ruíz I, Pahissa A. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides. J Antimicrob Chemother. 2003 Sep;52(3):514-7. (PMID: 12917251) Gavaldà J, Len O, Miró JM, Muñoz P, Montejo M, Alarcón A, de la Torre-Cisneros J, Peña C, Martínez-Lacasa X, Sarria C, Bou G, Aguado JM, Navas E, Romeu J, Marco F, Torres C, Tornos P, Planes A, Falcó V, Almirante B, Pahissa A. Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone. Ann Intern Med. 2007 Apr 17;146(8):574-9. (PMID: 17438316) Miro JM, Cervera C, Garcia-de-la-Maria C, Del Rio A, Armero Y, Mestres CA, Grau JM, Marco F, Moreno A. Success of ampicillin plus ceftriaxone rescue therapy for a relapse of Enterococcus faecalis native-valve endocarditis and in vitro data on double beta-lactam activity. Scand J Infect Dis. 2008;40(11-12):968-72. (PMID: 18767002) Peterson SC, Lau TTY, Ensom MHH. Combination of Ceftriaxone and Ampicillin for the Treatment of Enterococcal Endocarditis: A Qualitative Systematic Review. Ann Pharmacother. 2017 Jun;51(6):496-503. (PMID: 28166656) Lorenzo MP, Kidd JM, Jenkins SG, Nicolau DP, Housman ST. In vitro activity of ampicillin and ceftriaxone against ampicillin-susceptible Enterococcus faecium. J Antimicrob Chemother. 2019 Aug 01;74(8):2269-2273. (PMID: 31050740) Smith JR, Barber KE, Raut A, Aboutaleb M, Sakoulas G, Rybak MJ. β-Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium. J Antimicrob Chemother. 2015;70(6):1738-43. (PMID: PMC454258225645208) Chuang YC, Lin HY, Chen PY, Lin CY, Wang JT, Chang SC. Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose. Clin Microbiol Infect. 2016 Oct;22(10):890.e1-890.e7. (PMID: 27475738) Kanjilal S, Kalil AC, Klompas M. What Is the Best Treatment for Vancomycin-Resistant Enterococcal Bloodstream Infections? Crit Care Med. 2018 Oct;46(10):1700-1703. (PMID: 30216308) Chuang YC, Wang JT, Lin HY, Chang SC. Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis. BMC Infect Dis. 2014 Dec 13;14:687. (PMID: PMC426995125495779) Kim SG, Becattini S, Moody TU, Shliaha PV, Littmann ER, Seok R, Gjonbalaj M, Eaton V, Fontana E, Amoretti L, Wright R, Caballero S, Wang ZX, Jung HJ, Morjaria SM, Leiner IM, Qin W, Ramos RJJF, Cross JR, Narushima S, Honda K, Peled JU, Hendrickson RC, Taur Y, van den Brink MRM, Pamer EG. Microbiota-derived lantibiotic restores resistance against vancomycin-resistant Enterococcus. Nature. 2019 Aug;572(7771):665-669. (PMID: PMC671750831435014) Jeong S, Lee Y, Yun CH, Park OJ, Han SH. Propionate, together with triple antibiotics, inhibits the growth of Enterococci. J Microbiol. 2019 Nov;57(11):1019-1024. (PMID: 31659687) Bolocan AS, Upadrasta A, Bettio PHA, Clooney AG, Draper LA, Ross RP, Hill C. Evaluation of Phage Therapy in the Context of Enterococcus faecalis and Its Associated Diseases. Viruses. 2019 Apr 20;11(4). (PMID: PMC652117831010053) Barros J, Melo LDR, Poeta P, Igrejas G, Ferraz MP, Azeredo J, Monteiro FJ. Lytic bacteriophages against multidrug-resistant Staphylococcus aureus, Enterococcus faecalis and Escherichia coli isolates from orthopaedic implant-associated infections. Int J Antimicrob Agents. 2019 Sep;54(3):329-337. (PMID: 31229670) Chatterjee A, Johnson CN, Luong P, Hullahalli K, McBride SW, Schubert AM, Palmer KL, Carlson PE, Duerkop BA. Bacteriophage Resistance Alters Antibiotic-Mediated Intestinal Expansion of Enterococci. Infect Immun. 2019 Jun;87(6). (PMID: PMC652965530936157) Hullahalli K, Rodrigues M, Palmer KL. Exploiting CRISPR-Cas to manipulate Enterococcus faecalis populations. Elife. 2017 Jun 23;6. (PMID: PMC549126428644125) Prematunge C, MacDougall C, Johnstone J, Adomako K, Lam F, Robertson J, Garber G. VRE and VSE Bacteremia Outcomes in the Era of Effective VRE Therapy: A Systematic Review and Meta-analysis. Infect Control Hosp Epidemiol. 2016 Jan;37(1):26-35. (PMID: PMC470750826434609) Duan Y, Llorente C, Lang S, Brandl K, Chu H, Jiang L, White RC, Clarke TH, Nguyen K, Torralba M, Shao Y, Liu J, Hernandez-Morales A, Lessor L, Rahman IR, Miyamoto Y, Ly M, Gao B, Sun W, Kiesel R, Hutmacher F, Lee S, Ventura-Cots M, Bosques-Padilla F, Verna EC, Abraldes JG, Brown RS, Vargas V, Altamirano J, Caballería J, Shawcross DL, Ho SB, Louvet A, Lucey MR, Mathurin P, Garcia-Tsao G, Bataller R, Tu XM, Eckmann L, van der Donk WA, Young R, Lawley TD, Stärkel P, Pride D, Fouts DE, Schnabl B. Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. Nature. 2019 Nov;575(7783):505-511. (PMID: PMC687293931723265) Garrett WS. Enterococcus in Graft-versus-Host Disease. N Engl J Med. 2020 Mar 12;382(11):1064-1066. (PMID: 32160669) Stein-Thoeringer CK, Nichols KB, Lazrak A, Docampo MD, Slingerland AE, Slingerland JB, Clurman AG, Armijo G, Gomes ALC, Shono Y, Staffas A, Burgos da Silva M, Devlin SM, Markey KA, Bajic D, Pinedo R, Tsakmaklis A, Littmann ER, Pastore A, Taur Y, Monette S, Arcila ME, Pickard AJ, Maloy M, Wright RJ, Amoretti LA, Fontana E, Pham D, Jamal MA, Weber D, Sung AD, Hashimoto D, Scheid C, Xavier JB, Messina JA, Romero K, Lew M, Bush A, Bohannon L, Hayasaka K, Hasegawa Y, Vehreschild MJGT, Cross JR, Ponce DM, Perales MA, Giralt SA, Jenq RR, Teshima T, Holler E, Chao NJ, Pamer EG, Peled JU, van den Brink MRM. Lactose drives Enterococcus expansion to promote graft-versus-host disease. Science. 2019 Nov 29;366(6469):1143-1149. (PMID: PMC700398531780560) Ben Braïek O, Smaoui S. Enterococci: Between Emerging Pathogens and Potential Probiotics. Biomed Res Int. 2019;2019:5938210. (PMID: PMC655624731240218) Weber SG, Huang SS, Oriola S, Huskins WC, Noskin GA, Harriman K, Olmsted RN, Bonten M, Lundstrom T, Climo MW, Roghmann MC, Murphy CL, Karchmer TB, Society for Healthcare Epidemiology of America. Association of Professionals in Infection Control and Epidemiology Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force. Infect Control Hosp Epidemiol. 2007 Mar;28(3):249-60. (PMID: 17326014) Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, Farr BM, SHEA SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol. 2003 May;24(5):362-86. (PMID: 12785411) Mac S, Fitzpatrick T, Johnstone J, Sander B. Vancomycin-resistant enterococci (VRE) screening and isolation in the general medicine ward: a cost-effectiveness analysis. Antimicrob Resist Infect Control. 2019;8:168. (PMID: PMC682090531687132) De Angelis G, Cataldo MA, De Waure C, Venturiello S, La Torre G, Cauda R, Carmeli Y, Tacconelli E. Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis. J Antimicrob Chemother. 2014 May;69(5):1185-92. (PMID: 24458513) Vehreschild MJGT, Haverkamp M, Biehl LM, Lemmen S, Fätkenheuer G. Vancomycin-resistant enterococci (VRE): a reason to isolate? Infection. 2019 Feb;47(1):7-11. (PMID: 30178076) LeDell K, Muto CA, Jarvis WR, Farr BM. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol. 2003 Sep;24(9):639-41. (PMID: 14510243) |
| تواريخ الأحداث: | Date Created: 20220502 |
| رمز التحديث: | 20240629 |
| PMID: | 33620836 |
| Book AN: | NBK567759 |
| قاعدة البيانات: | MEDLINE |
| الوصف غير متاح. |